Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U0XG
|
||||
Former ID |
DNC005908
|
||||
Drug Name |
N-(tert-butoxycarbonyl)-methionyl-glycine-nitrile
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527885] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H21N3O3S
|
||||
Canonical SMILES |
CC(C)(C)OC(=O)NC(CCSC)C(=O)NCC#N
|
||||
InChI |
1S/C12H21N3O3S/c1-12(2,3)18-11(17)15-9(5-8-19-4)10(16)14-7-6-13/h9H,5,7-8H2,1-4H3,(H,14,16)(H,15,17)/t9-/m0/s1
|
||||
InChIKey |
PDUKBZKBRGAZFC-VIFPVBQESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | Inhibitor | [527885] | |
Cathepsin L | Target Info | Inhibitor | [527885] | ||
Cathepsin S | Target Info | Inhibitor | [527885] | ||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.